The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 03, 2023

Filed:

Dec. 09, 2019
Applicants:

Lucie Carrier, Hamburg, DE;

Thomas Eschenhagen, Hamburg, DE;

Thomas Voit, London, GB;

Giulia Mearini, Hamburg, DE;

Oliver Mueller, Heikendorf, DE;

Doreen Stimpel, Hamburg, DE;

Inventors:

Lucie Carrier, Hamburg, DE;

Thomas Eschenhagen, Hamburg, DE;

Thomas Voit, London, GB;

Giulia Mearini, Hamburg, DE;

Oliver Mueller, Heikendorf, DE;

Doreen Stimpel, Hamburg, DE;

Julia Mourot-Filiatre, Brasilia, BR;

Assignee:

Other;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 15/86 (2006.01); C07K 14/47 (2006.01); A61K 35/34 (2015.01); C12N 5/074 (2010.01); C12N 5/077 (2010.01); A61K 48/00 (2006.01); C12N 7/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); A61K 35/34 (2013.01); A61K 48/0058 (2013.01); C07K 14/4716 (2013.01); C12N 5/0657 (2013.01); C12N 5/0696 (2013.01); C12N 7/00 (2013.01); C12N 2506/45 (2013.01); C12N 2750/14143 (2013.01); C12N 2799/025 (2013.01); C12N 2830/007 (2013.01); C12N 2830/008 (2013.01);
Abstract

The present invention relates to a gene therapy vector which is useful in the treatment or prevention of hypertrophic cardiomyopathy in a subject in need thereof. The gene therapy vector of the invention comprises a nucleic acid sequence encoding a cardiac sarcomeric protein and a cardiomyocyte-specific promoter which is operably linked to said nucleic acid sequence. The invention furthermore relates to a cell which comprises the gene therapy vector. Pharmaceutical compositions which comprise the gene therapy vector and/or a cell comprising said vector are also provided. In another aspect, the invention relates to a method for treating or preventing hypertrophic cardiomyopathy in a subject by introducing the gene therapy vector of the invention into a subject in need of treatment.


Find Patent Forward Citations

Loading…